US Stock MarketDetailed Quotes
VCNX Vaccinex
- 2.7900
- -1.2400-30.77%
Close Oct 31 16:00 ET
- 2.8500
- +0.0600+2.15%
Post 19:57 ET
7.80MMarket Cap-704P/E (TTM)
4.8100High2.7600Low454.16KVolume4.0100Open4.0300Pre Close1.67MTurnover30.04%Turnover RatioLossP/E (Static)2.80MShares13.440052wk High-1.84P/B4.22MFloat Cap1.390052wk Low--Dividend TTM1.51MShs Float2568.3000Historical High--Div YieldTTM50.87%Amplitude1.3900Historical Low3.6840Avg Price1Lot Size
About Vaccinex Company
Vaccinex, Inc. operates as a clinical-stage biotechnology company. It engages in the development of targeted bio therapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The firm focuses on the development of Pepinemab for the treatment of non-small cell lung cancer, or NSCLC, osteosarcoma, melanoma, and Huntington’s disease. Its product pipeline includes the SEMA4D antibody platform and ActivMAb antibody discovery platform. The company was founded by Maurice Zauderer in April 2001 and is headquartered in Rochester, NY.
Company Profile
SymbolVCNX
Company NameVaccinex
Listing DateAug 9, 2018
Issue Price12.00
Founded2001
CEODr. Maurice Zauderer, PhD
MarketNASDAQ
Employees40
Fiscal Year Ends12-31
Address1895 Mount Hope Avenue
CityRochester
ProvinceNew York
CountryUnited States of America
Zip Code14620
Phone1-585-271-2700
Websitehttp://www.vaccinex.com
Company Executives
- Name
- Position
- Salary
- Dr. Maurice Zauderer, PhD
- Director, President and Chief Executive Officer
- 430.28K
- Elizabeth Evans
- Chief Operating Officer and Senior Vice President, Translational Medicine and Discovery
- 303.21K
- Dr. Ernest S. Smith, PhD
- Senior Vice President, Research and Chief Scientific Officer
- 308.90K
- Jill Sanchez
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Albert D. Friedberg
- Chairman of the Board
- 75.00K
- Gerald E. Van Strydonck
- Independent Director
- 90.00K
- Jacob B. Frieberg
- Independent Director
- 75.00K
- Barbara Yanni
- Independent Director
- 85.00K
- Dr. Bala S. Manian, PhD
- Independent Director
- 82.50K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data